Trials / Unknown
UnknownNCT01202292
Group Motivational Intervention in Overweight/Obese Patients.
Group Motivational Intervention in Overweight/Obese Patients in Primary Prevention of Cardiovascular Disease in the Primary Healthcare Area.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,200 (estimated)
- Sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of IMOAP study is to assess whether the efficacy of the healthcare professionals' usual practices, together with a motivational group intervention (delivered by a nurse trained by an expert psychologist), is more effective than an isolated traditional intervention on weight loss and its maintenance in overweight and obese patients. Furthermore, the study will evaluate whether this result has a positive impact on quality of life, changes in eating habits, and a reduction in the associated cardiovascular risk factors and overall cardiovascular risk.
Detailed description
The global mortality caused by cardiovascular disease increases with weight. The Framingham study showed that obesity is a cardiovascular risk factor independent of other risks such as type 2 diabetes mellitus, dyslipidemia and smoking. Moreover, the main problem in the management of weight-loss is its maintenance, if it is achieved. We have designed a study in two geographically separated groups, one of which would receive the group motivational intervention, and the other one would receive the usual follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Behavioral (e.g., Psychotherapy, Lifestyle Counseling) | Group motivational intervention consist in expert psychologist 32 monthly sessions (group intervention) on top of the diet plus exercise |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-10-01
- Completion
- 2010-12-01
- First posted
- 2010-09-15
- Last updated
- 2010-10-01
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01202292. Inclusion in this directory is not an endorsement.